Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

ClinicalTrials.gov ID: NCT02489227

Public ClinicalTrials.gov record NCT02489227. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Parallel-Group, Active-Control Study to Compare the Efficacy and Safety of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

Study identification

NCT ID
NCT02489227
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Coherus Oncology, Inc.
Industry
Enrollment
545 participants

Conditions and interventions

Interventions

  • CHS-1420 Drug
  • Adalimumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2015
Primary completion
May 5, 2016
Completion
Feb 28, 2017
Last update posted
Apr 7, 2020

2015 – 2017

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Sadra Sasha Jazayeri, MD Phoenix Arizona 85032
Encino Research Center Encino California 91436
Center for Dermatology and Laser Surgery Sacramento California 95819
Kenneth M Stein, MD Santa Rosa California 95405
HealthCare Partners Medical Group Clinical Research Center Torrance California 90503
Horizons Clinical Research Center, LLC. Denver Colorado 80220
New England Research Associates LLC Trumbull Connecticut 06611
Francisco A Kerdel, MD Coral Gables Florida 33134
Linda Tripodis Murray, DO Pinellas Park Florida 33781
ACRC-Dermatology West Palm Beach Florida 33406
Mark A Knautz, MD Marietta Georgia 30060
The Indiana Clinical Trials Center Plainfield Indiana 46168
Grekin Skin Institute Warren Michigan 48088
Jack C Scott, MD Edina Minnesota 55435
Central Dermatology St Louis Missouri 63117
Craig L Leonardi, MD St Louis Missouri 63117
PMG Research of Raleigh, LLC Cary North Carolina 27518
Box Arthritis & Rheumetology of the Carolinas Charlotte North Carolina 28210
Michael Joseph Noss, MD Cincinnati Ohio 45249
Central Sooner Research Norman Oklahoma 73031
Health Research of Oklahoma Oklahoma City Oklahoma 73103
Dermatology and Skin Surgery Center, PC Exton Pennsylvania 19341
James Henry Kopp, MD Anderson South Carolina 29621
PMG Research of Bristol, LLC Bristol Tennessee 37620
Arlington Research Center, Inc. Arlington Texas 76011
Center for Clinical Studies TMC/ Museum District Office Houston Texas 77004
Center for Clinical Studies Houston Texas 77065
Center for Clinical Studies Webster Texas 77598

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02489227, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 7, 2020 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02489227 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →